FOXO6 and metastatic malignant neoplasm in the lymph nodes: While larger tumor size, upper tumor site, prominent serosal invasion, lymph node metastasis and FOXO6 overexpression (all P < 0.05) were unfavourable predictors for RFS (Table 2).